KRAS and pancreatic neoplasm: Tested for different types of KRAS mutated cell lines of pancreatic cancer [MIAPaCa-2 (G12C), MOH (G12R), PANC-1 (G12D)], and colon cancer [SW116 (G12A), SW948 (Q61L)], which observed significant inhibition of proliferation of cancer cells [184].